Filipa Silva-Moreira
Rua Dr. António Bernardino De Almeida
Porto, Portugal
Porto, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Bioengineered Tumor-Stroma Prostate Cancer In Vitro Models for Screening Therapeutics.
Journal: Biotechnology and bioengineering
Published: November 15, 2024
Combination of MLo-1508 with sunitinib for the experimental treatment of papillary renal cell carcinoma.
Journal: Frontiers in oncology
Published: March 12, 2024
EHMT2/G9a and EZH2: Epimarkers in testicular germ cell tumors.
Journal: Andrology
Published: October 11, 2023
Novel Insights on the Role of Epigenetics in Androgen Receptor's Expression in Prostate Cancer.
Journal: Biomolecules
Published: August 28, 2023
G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 17, 2022
From Therapy Resistance to Targeted Therapies in Prostate Cancer.
Journal: Frontiers in oncology
Published: February 16, 2022
Epigenetically-regulated miR-30a/c-5p directly target TWF1 and hamper ccRCC cell aggressiveness.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: December 21, 2021
Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 18, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026